by Matt Guldin | December 13, 2018
Key Takeaways Current vendor solutions are limited and generally require additional advisory services. Few available solutions offer workflow integration, especially across post-acute care settings, to assist in the execution of bundled episodes. Larger HCOs will weather the shift to bundled payments more easily than their smaller counterparts, especially as bundled
by Chilmark Team | December 10, 2018
The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define new revenue streams, weaker ones faded from view through acquisitions or leveraged buy-out. Meanwhile, funding for 'digital health' start-ups continued to increase, though it likely hit the high water mark
by Chilmark Team | November 29, 2018
As is our custom here, we like to look back on our predictions for the closing year and see just how well we did. Some years we do amazingly well, others we over-reach and miss on quite a few. For 2018, we got seven of our 13 predictions spot-on, two
by Matt Guldin | November 27, 2018
Recent comments by Secretary Alex M. Azar II indicate changes ahead Key Takeaways Mandatory alternative payment model (APM) is coming for radiation oncologists. HHS has not yet released many details but The American Society for Radiation Oncology’s (ASTRO) radiation oncology-APM (RO-APM) is a likely useful proxy for what this
by John Moore III | April 13, 2018
This webinar complements the release of our 2018 Patient Relationship Management Market Scan Report. The webinar is presented by the analyst behind the report, Brian Eastwood. To learn more about the report or to purchase, please click here. Enjoy! This report is included in qualifying Chilmark Advisory Service subscriptions, and
by Chilmark Team | March 14, 2018
HIMSS18 Review 2 of 4 By Matt Guldin and Brian Eastwood Having returned and (mostly) recovered from HIMSS18 in Las Vegas, the Chilmark Research team wanted to share our thoughts on what we saw in presentations and heard in conversations. This post includes our analysis and insights on Care Management and
by John Moore lll | February 21, 2018
For those of you who are overwhelmed by looking through the HIMSS18 session schedule (and those of you who have been meaning to look but haven't gotten to it yet), here's Chilmark Research's short list of sessions we expect to be worthwhile, as chosen by our analyst team. It is
by Chilmark Team | December 15, 2017
Our favorite post of the year is this one. As analysts, we come together with our propeller hats on to collectively look ahead at the key trends in the year to come in the healthcare sector. While there are any number of predictions one might make for this dynamic market,
